NATURASON Trademark

Trademark Overview


On Wednesday, August 23, 2000, a trademark application was filed for NATURASON with the United States Patent and Trademark Office. The USPTO has given the NATURASON trademark a serial number of 76122111. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, July 8, 2003. This trademark is owned by EPIGENESIS Pharmaceuticals, Inc.. The NATURASON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, steroid hormone compound(s), including dehydroepiandrosterone derivatives and salts, for medical use, in the treatment of human and non-human animal respiratory, central nervous system, immune, endocrine, neoplastic and cardiovascular conditions, including bronchoconstriction, anxiety, Pre Menstrual Syndrome, Menopause symptoms, anxiety, lack of sleep, aggressive or ostensibly socially inappropriate behavior, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, pharmaceutical preparations for testing, preventing and therapeutically treating immune, central nervous system, endocrine, neoplastic, cardiovascular, respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, asthma, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, associated with the administration of certain drugs, including adenos...

General Information


Serial Number76122111
Word MarkNATURASON
Filing DateWednesday, August 23, 2000
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, July 8, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 15, 2002

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, steroid hormone compound(s), including dehydroepiandrosterone derivatives and salts, for medical use, in the treatment of human and non-human animal respiratory, central nervous system, immune, endocrine, neoplastic and cardiovascular conditions, including bronchoconstriction, anxiety, Pre Menstrual Syndrome, Menopause symptoms, anxiety, lack of sleep, aggressive or ostensibly socially inappropriate behavior, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, pharmaceutical preparations for testing, preventing and therapeutically treating immune, central nervous system, endocrine, neoplastic, cardiovascular, respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, asthma, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, associated with the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, eg cancers which metastasized to the lung(s), breast and prostate included
Pseudo MarkNATURA SON

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 21, 2000
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events


Event DateEvent Description
Wednesday, September 24, 2003ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 7, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 15, 2002PUBLISHED FOR OPPOSITION
Wednesday, September 25, 2002NOTICE OF PUBLICATION
Monday, July 15, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 5, 2002ASSIGNED TO EXAMINER
Wednesday, June 19, 2002Sec. 1(B) CLAIM ADDED
Wednesday, June 19, 2002SEC. 1(A) CLAIM DELETED
Wednesday, June 12, 2002EXAMINERS AMENDMENT MAILED
Tuesday, March 5, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 7, 2001FINAL REFUSAL MAILED
Friday, August 10, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 7, 2001NON-FINAL ACTION MAILED
Wednesday, January 24, 2001ASSIGNED TO EXAMINER
Tuesday, January 23, 2001ASSIGNED TO EXAMINER